Cargando…

Cardiac Telocytes 16 Years on—What Have We Learned So Far, and How Close Are We to Routine Application of the Knowledge in Cardiovascular Regenerative Medicine?

The regeneration of a diseased heart is one of the principal challenges of modern cardiovascular medicine. There has been ongoing research on stem-cell-based therapeutic approaches. A cell population called telocytes (TCs) described only 16 years ago largely contributed to the research area of cardi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klein, Martin, Csöbönyeiová, Mária, Žiaran, Stanislav, Danišovič, Ľuboš, Varga, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8535888/ https://www.ncbi.nlm.nih.gov/pubmed/34681601 http://dx.doi.org/10.3390/ijms222010942

Ejemplares similares

Telocytes in the Female Reproductive System: Up-to-Date Knowledge, Challenges and Possible Clinical Applications
por: Klein, Martin, et al.
Publicado: (2022)

Tissue Engineering of the Urethra: From Bench to Bedside
por: Pastorek, Dusan, et al.
Publicado: (2021)

COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020)

Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022)

Cells Involved in Urethral Tissue Engineering: Systematic Review
por: Culenova, Martina, et al.
Publicado: (2019)

The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)

Brain Tumor Immunotherapy: What have We Learned so Far?
por: Van Gool, Stefaan Willy
Publicado: (2015)

Editorial: Cancer Nanotheranostics: What Have We Learned So Far?
por: Conde, João, et al.
Publicado: (2016)

OMICs in Cariology and Endodontology – what have we learned so far?
por: Zaura, Egija
Publicado: (2017)

Circadian Clocks in Fish—What Have We Learned so far?
por: Frøland Steindal, Inga A., et al.
Publicado: (2019)

Offline: COVID-19—what have we learned so far?
por: Horton, Richard
Publicado: (2020)

What have we learnt so far from COVID-19?
por: Doherty, Peter C.
Publicado: (2021)

Bleeding in COVID Patients: What We Have Understood So Far
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Ovarian Cancer Radiosensitivity: What Have We Understood So Far?
por: Barcellini, Amelia, et al.
Publicado: (2022)

ECMO Retrieval Program: What Have We Learned So Far
por: Krasivskyi, Ihor, et al.
Publicado: (2023)

COVID-19 and the heart: what we have learnt so far
por: Shaha, Kunal Bikram, et al.
Publicado: (2020)

What we know so far
Publicado: (2021)

Induced Pluripotent Stem Cell-Derived Organoids: Their Implication in COVID-19 Modeling
por: Csöbönyeiová, Mária, et al.
Publicado: (2023)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Bioengineered Scaffolds as Substitutes for Grafts for Urethra Reconstruction
por: Culenova, Martina, et al.
Publicado: (2019)

Recently Discovered Interstitial Cell Population of Telocytes: Distinguishing Facts from Fiction Regarding Their Role in the Pathogenesis of Diverse Diseases Called “Telocytopathies”
por: Varga, Ivan, et al.
Publicado: (2019)

Campylobacter Phage Isolation and Characterization: What We Have Learned So Far
por: Jäckel, Claudia, et al.
Publicado: (2019)

Editorial: Cancer Epidemiology in China: What We Have Learnt So Far?
por: Chen, Tianhui, et al.
Publicado: (2020)

MRD Tailored Therapy in AML: What We Have Learned So Far
por: Ngai, Lok Lam, et al.
Publicado: (2021)

Sarcopenia in chronic kidney disease: what have we learned so far?
por: Sabatino, Alice, et al.
Publicado: (2020)

The Role of Extracellular Matrix and Hydrogels in Mesenchymal Stem Cell Chondrogenesis and Cartilage Regeneration
por: Strecanska, Magdalena, et al.
Publicado: (2022)

Tissue Engineering and Stem Cell Therapy in Neurogenic Bladder Dysfunction: Current and Future Perspectives
por: Topoliova, Katarina, et al.
Publicado: (2023)

Anabaenopeptins: What We Know So Far
por: Monteiro, Patrick Romano, et al.
Publicado: (2021)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Telocytes in regenerative medicine
por: Bei, Yihua, et al.
Publicado: (2015)

Toxicity and cellular uptake of gold nanoparticles: what we have learned so far?
por: Alkilany, Alaaldin M., et al.
Publicado: (2010)

Neural synchrony within the motor system: what have we learned so far?
por: van Wijk, Bernadette C. M., et al.
Publicado: (2012)

NEO adjuvant chemotherapy in breast cancer: What have we learned so far?
por: Raut, Nirmal V, et al.
Publicado: (2010)

Combining inclusive and exclusive data analyses-what have we learned so far?
por: Kittel, E W
Publicado: (1973)

Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022)

Interaction between Insects, Toxins, and Bacteria: Have We Been Wrong So Far?
por: Tetreau, Guillaume
Publicado: (2018)

Helping children with reading difficulties: some things we have learned so far
por: McArthur, Genevieve, et al.
Publicado: (2017)

Mitochondrial Neurogastrointestinal Encephalomyopathy: Into the Fourth Decade, What We Have Learned So Far
por: Pacitti, Dario, et al.
Publicado: (2018)

The COVID-19 Pandemic and Cardiovascular Complications: What Have We Learned So Far?
por: Walsh, Mary Norine, et al.
Publicado: (2020)

Gene Therapy in Rare Respiratory Diseases: What Have We Learned So Far?
por: Bañuls, Lucía, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6ijdq42au4lq3ct3ar87k05mic